Search

Search Results
Results 11 - 20 of 132 for Radiotherapy
  • Nanobiotix Files for First Market Approval of NBTXR3 Product in Europe
    News - 14 Sep 2016
    NANOBIOTIX, a late clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, has filed for market approval (CE Marking) in Europe for its lead product, a...
  • Nanobiotix’s NBTXR3 NanoXray Phase I Clinical Study Results Presented at ASCO
    News - 2 Jun 2014
    NANOBIOTIX, a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announced the successful completion of the first in human study of its lead NanoXray...
  • Digital Surf
    Supplier Profile
    Founded in 1989, Digital Surf is a leading provider of innovative solutions for micro and nano-surface metrology for use in research laboratory, industrial and production environments. Our company is...
  • H.C. Starck Solutions
    Supplier Profile
    H.C. Starck Solutions converts technology metal powders: molybdenum (Mo), niobium (Nb), tantalum (Ta) and tungsten (W) into semi-finished, finished, and customer-specific products through production...
  • NUS Nanoscience & Nanotechnology Initiative
    Supplier Profile
    The National University of Singapore (NUS) acknowledges the global trend that nanotechnology is expected to be a key technology. NUS, in tradition of spearheading cutting-edge research programs, has...
  • Oxford Instruments Nanoscience
    Supplier Profile
    Creating high performance cryogenic and cryogen free environments for ultra low temperature and high magnetic field applications in physics, chemistry and materials science research down to the atomic...
  • Nanoprobes Inc.
    Supplier Profile
    Nanoprobes was founded to develop the most sensitive reagents and technology for detecting biological molecules. Our unique gold labeling technology uses chemically cross-linked metal clusters and...
  • Company Announces Exciting Preclinical Results Using Patented Nanotechnology to Fight Tumors
    News - 18 May 2009
    Nanobiotix, an emerging nanomedicine company, announced today exciting preclinical results using its patented nanoXray therapeutics platform to fight tumors. The preclinical study, performed at...
  • Positive Intermediate Results from Nanobiotix’s NBTXR3 Phase I/II Clinical Trial in Head and Neck Cancer
    News - 10 Jun 2015
    NANOBIOTIX (Paris:NANO) (Euronext: NANO – ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announces positive...
  • The Future of Nanotechnology in Cancer Treatment
    Article - 2 Jun 2021
    Scientists are currently investigating nanotechnology in cancer treatment to improve therapeutic efficacy and reduce adverse side effects.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback